GBSciences Overview
- Year Founded
-
2001
- Status
-
Public
- Employees
-
19
- Stock Symbol
-
GBLX
- Investments
-
3
GBSciences General Information
Description
GB Sciences Inc is active in the healthcare sector. The company is engaged in developing and utilizing technologies in plant biology, cultivation, and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for a range of ailments. The company's intellectual property covers various medical conditions, from which five drug development programs are in the preclinical stage of drug development including its formulations for Parkinson's disease (PD), chronic pain, cytokine release syndrome, depression, and cardiovascular therapeutic programs.
Contact Information
Website
www.gbsciences.comCorporate Office
- 3550 West Teco Avenue
- Las Vegas, NV 89118
- United States
Corporate Office
- 3550 West Teco Avenue
- Las Vegas, NV 89118
- United States
GBSciences Stock Performance
As of 13-Nov-2026, GBSciences’s current market cap is $40.7K.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $40.7K | 53.7K |
GBSciences Financials Summary
As of 31-Dec-2024, GBSciences has a trailing 12-month revenue of $97.2K.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
|---|---|---|---|---|
| EV | 3,495 | 4,216 | 7,947 | 9,343 |
| Revenue | 97 | 0 | 0 | 0 |
| EBITDA | (848) | (1,142) | (3,885) | 399 |
| Net Income | (1,043) | (1,362) | (4,125) | (531) |
| Total Assets | 94 | 103 | 352 | 2,550 |
| Total Debt | 1,994 | 1,759 | 1,396 | 1,385 |
GBSciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GBSciences Comparisons
Industry
Financing
Details
GBSciences Competitors (5)
One of GBSciences’s 5 competitors is AXIM Biotechnologies, a Corporation company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AXIM Biotechnologies | Corporation | New York, NY | ||||
| Revive Therapeutics | Corporation | Toronto, Canada | ||||
| Tetra Bio-Pharma | Corporation | Orleans, Canada | ||||
| Corbus Pharmaceuticals Holdings | Formerly VC-backed | Norwood, MA | ||||
| Skye Bioscience | Formerly VC-backed | San Diego, CA |
GBSciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
GBSciences Patents
GBSciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230263766-A1 | Cannabinoid-containing formulations for parkinsonian movement disorders | Inactive | 28-Sep-2021 | ||
| US-20240316002-A1 | Cannabinoid-containing formulations for parkinsonian movement disorders | Pending | 28-Sep-2021 | ||
| US-10653640-B2 | Cannabinoid-containing complex mixtures for the treatment of neurodegenerative diseases | Active | 11-Oct-2016 | ||
| US-11980592-B2 | Cannabinoid-containing complex mixtures for the treatment of neurodegenerative diseases | Active | 11-Oct-2016 | ||
| US-20180098948-A1 | Cannabinoid-containing complex mixtures for the treatment of neurodegenerative diseases | Active | 11-Oct-2016 | A61K31/658 |
GBSciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
GBSciences Investments (3)
GBSciences’s most recent deal was a Joint Venture with Joint Venture (GB Sciences and Los Coyotes). The deal was made on 02-Aug-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture (GB Sciences and Los Coyotes) | 02-Aug-2017 | Joint Venture | Other Pharmaceuticals and Biotechnology | ||
| GBSciences (Two Medical Marijuana Establishment Licenses in Nevada) | 04-Oct-2016 | Corporate Asset Purchase | Buildings and Property | ||
| LaurelCo | 25-Jul-2014 | Corporate | Other Pharmaceuticals and Biotechnology |
GBSciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
GBSciences FAQs
-
When was GBSciences founded?
GBSciences was founded in 2001.
-
Where is GBSciences headquartered?
GBSciences is headquartered in Las Vegas, NV.
-
What is the size of GBSciences?
GBSciences has 19 total employees.
-
What industry is GBSciences in?
GBSciences’s primary industry is Drug Discovery.
-
Is GBSciences a private or public company?
GBSciences is a Public company.
-
What is GBSciences’s stock symbol?
The ticker symbol for GBSciences is GBLX.
-
What is the current market cap of GBSciences?
The current market capitalization of GBSciences is $40.7K.
-
What is GBSciences’s current revenue?
The trailing twelve month revenue for GBSciences is $97.2K.
-
Who are GBSciences’s competitors?
AXIM Biotechnologies, Revive Therapeutics, Tetra Bio-Pharma, Corbus Pharmaceuticals Holdings, and Skye Bioscience are competitors of GBSciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
